Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola

The Interventional Pediatrics unit is initiating studies that examine how immune‑mediated conditions affect maternal health and fetal outcomes in young patients, aiming to improve diagnostics and therapeutic strategies for pregnancy‑related complications.

• Immune‑mediated uterine inflammation
• Maternal‑fetal pharmacokinetic modeling
• Safety of biologic agents during pregnancy

The site, Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, collaborates with obstetric specialists to broaden its pediatric scope.

In the realm of immune system diseases, the department conducts pediatric trials evaluating novel biologics for Crohn's disease, seeking to determine treatment effectiveness and safety in children who have not responded to standard therapies.

• Biologic efficacy in pediatric Crohn's
• Pharmacokinetic assessment of new agents
• Long‑term safety monitoring

This work supports the hospital’s mission to advance care for children with chronic inflammatory disorders.

Researchers are exploring therapeutic options for Dravet syndrome, a severe epileptic encephalopathy, by testing the tolerability and impact of emerging medicines on infant brain function, with the goal of ensuring safety for the youngest patients.

• Safety and tolerability in infants
• Neurodevelopmental outcome measures
• Drug distribution in the central nervous system

The pediatric team at the Brussels hospital leverages cutting‑edge monitoring to protect vulnerable children.

The unit investigates how intestinal inflammation influences growth and nutrition in children with Crohn's disease, aiming to refine therapeutic approaches that protect the digestive tract.

• Assessment of intestinal healing
• Nutritional status monitoring
• Oral formulation suitability for children

Collaboration with gastroenterology experts enhances the site’s capacity to deliver comprehensive care.

A broader program examines fundamental immune system processes underlying pediatric inflammatory conditions, seeking biomarkers that predict response to treatment across diseases and underpinning personalized medicine initiatives.

• Biomarker discovery
• Cellular immune profiling
• Correlation of immune markers with clinical outcomes

Ongoing studies at Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola aim to translate laboratory findings into bedside improvements.